Lördag 18 Juli | 12:52:07 Europe / Stockholm
Est. tid*
2027-07-16 07:45 Kvartalsrapport 2027-Q2
2027-05-04 N/A Årsstämma
2027-04-29 07:45 Kvartalsrapport 2027-Q1
2027-02-03 07:45 Bokslutskommuniké 2026
2026-10-21 07:45 Kvartalsrapport 2026-Q3
2026-07-16 - Kvartalsrapport 2026-Q2
2026-05-07 - X-dag ordinarie utdelning ALIF B 1.50 SEK
2026-05-06 - Årsstämma
2026-04-28 - Kvartalsrapport 2026-Q1
2026-02-04 - Bokslutskommuniké 2025
2025-10-23 - Kvartalsrapport 2025-Q3
2025-07-15 - Kvartalsrapport 2025-Q2
2025-05-09 - X-dag ordinarie utdelning ALIF B 0.75 SEK
2025-05-08 - Årsstämma
2025-04-25 - Kvartalsrapport 2025-Q1
2025-02-05 - Bokslutskommuniké 2024
2024-10-23 - Kvartalsrapport 2024-Q3
2024-07-15 - Kvartalsrapport 2024-Q2
2024-05-10 - X-dag ordinarie utdelning ALIF B 0.50 SEK
2024-05-08 - Årsstämma
2024-04-24 - Kvartalsrapport 2024-Q1
2024-02-02 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-05-05 - X-dag ordinarie utdelning ALIF B 1.20 SEK
2023-05-04 - Årsstämma
2023-04-26 - Kvartalsrapport 2023-Q1
2023-02-02 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-05-06 - X-dag ordinarie utdelning ALIF B 2.00 SEK
2022-05-05 - Årsstämma
2022-04-28 - Kvartalsrapport 2022-Q1
2022-02-04 - Bokslutskommuniké 2021
2021-10-22 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-05-06 - X-dag ordinarie utdelning ALIF B 1.50 SEK
2021-05-05 - Årsstämma
2021-04-28 - Kvartalsrapport 2021-Q1
2021-02-03 - Bokslutskommuniké 2020
2020-11-20 - X-dag bonusutdelning ALIF B 0.5
2020-11-19 - Extra Bolagsstämma 2020
2020-10-22 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-05-27 - Split ALIF B 1:4
2020-05-08 - X-dag ordinarie utdelning ALIF B 0.00 SEK
2020-05-07 - Årsstämma
2020-04-28 - Kvartalsrapport 2020-Q1
2020-02-06 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-07-12 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag ordinarie utdelning ALIF B 2.20 SEK
2019-05-09 - Årsstämma
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-12 - Bokslutskommuniké 2018
2018-12-20 - Extra Bolagsstämma 2018
2018-11-07 - Kvartalsrapport 2018-Q3
2018-07-13 - Kvartalsrapport 2018-Q2
2018-06-01 - X-dag ordinarie utdelning ALIF B 2.20 SEK
2018-05-31 - Årsstämma
2018-04-27 - Kvartalsrapport 2018-Q1
2018-02-13 - Bokslutskommuniké 2017
2017-10-26 - Kvartalsrapport 2017-Q3
2017-07-17 - Kvartalsrapport 2017-Q2
2017-05-30 - X-dag ordinarie utdelning ALIF B 1.50 SEK
2017-05-29 - Årsstämma
2017-04-28 - Kvartalsrapport 2017-Q1
2017-02-16 - Bokslutskommuniké 2016
2016-10-27 - Kvartalsrapport 2016-Q3
2016-09-02 - X-dag ordinarie utdelning ALIF B 0.00 SEK
2016-09-01 - Årsstämma
2016-07-15 - Kvartalsrapport 2016-Q2
LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
AddLife är verksamt inom medicinteknikbranschen och fokuserar på utveckling, tillverkning och distribution av medicinsk utrustning och laboratorieprodukter. Bolagets produkter riktar sig till sjukvårdsinstitutioner och forskningslaboratorier. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. AddLife grundades år 2015 och har sitt huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Interim Report January 1 – June 30, 2026

2026-07-16 07:45:00

Positive development across AddLife’s companies

“AddLife’s companies are performing well across the board, with stronger margins, good growth and increased cash flow. Our improvement efforts are yielding clear results, and our recently acquired companies are making a significant contribution to earnings growth. At the same time, we are actively pursuing further acquisitions.”
Fredrik Dalborg, President and CEO

AddLife´s interim report for Q2 2026 is now available online at the company website. The interim report can be downloaded in pdf version. Visit https://reports-en.add.life/interim-report-q2-2026

SECOND QUARTER

  • Net sales increased by 6 percent to SEK 2,721 million (2,578). Adjusted for operations divested in December 2025, organic growth amounted to 4 percent and acquired growth amounted to 3 percent.
  • EBITA increased by 11 percent to SEK 342 million (307), corresponding to an EBITA margin of 12.6 percent (11.9).
  • Profit after tax increased by 30 percent to SEK 130 million (100).
  • Earnings per share amounted to SEK 1.06 (0.83).
  • Cash flow from operating activities amounted to SEK 165 million (119).
  • During the quarter, the acquisition of CoaChrom Diagnostica GmbH, Austria, was completed. The acquisition is expected to contribute annual net sales of approximately SEK 110 million.

JANUARY – JUNE, 2026

  • Net sales increased by 2 percent to SEK 5,366 million (5,280). Adjusted for operations divested in December 2025, organic growth amounted to 3 percent, acquired growth amounted to 2 percent, and exchange rate effects had a negative impact of 2 percent.
  • EBITA increased by 4 percent to SEK 674 million (650), corresponding to an EBITA margin of 12.6 percent (12.3). Exchange rate effects had a negative impact of 2 percent on EBITA.
  • Profit after tax increased by 17 percent to SEK 258 million (220).
  • Earnings per share amounted to SEK 2.11 (1.81). For the latest 12‑month period, earnings per share amounted to 4.89 (2.76).
  • Cash flow from operating activities amounted to SEK 269 million (359).
  • The equity ratio was 43 percent (43).
  • Return on working capital (P/WC) amounted to 61 percent (62).
  • During the interim period, two acquisitions were completed. The acquisitions are expected to contribute annual net sales of approximately SEK 185 million.

Stockholm, July 16, 2026

AddLife AB (publ)